Azitra (AZTR) Current Leases (2022 - 2026)
Azitra (AZTR) reported Current Leases of $240740.0 for Q1 2026, up 1.3% on a YoY basis from $237647.0 in Q1 2025, and down 5.88% quarter-over-quarter from $255776.0 in Q4 2025.
Azitra (AZTR) Current Leases (2022 - 2026) Analysis & Trends
Azitra has reported Current Leases for 5 years, with the latest figure at $240740.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 1.3% year-over-year to $240740.0; the trailing twelve-month figure through Mar 2026 stood at $240740.0 (up 1.3% YoY), and the FY2025 full-year result was $255776.0, changed 0.23% from the prior year.
- Current Leases for Q1 2026 stood at $240740.0, down from $255776.0 in the prior quarter.
- The five-year high for Current Leases was $310929.0 in Q1 2024, with the low at $14271.0 in Q3 2025.
- Historically, Current Leases has averaged $237515.7 across 5 years, with a median of $276839.0 in 2024.
- Annual changes were most pronounced in 2024 — Current Leases tumbled 94.86% — and 2025, when it jumped 1770.46%.
- Azitra's Current Leases stood at $287384.0 in 2022, then grew by 7.05% to $307655.0 in 2023, then declined by 17.06% to $255177.0 in 2024, then gained by 0.23% to $255776.0 in 2025, then retreated by 5.88% to $240740.0 in 2026.
- The last three Current Leases figures came in at $240740.0 (Q1 2026), $255776.0 (Q4 2025), and $14271.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Azitra | 20,900.00 | 20,900.00 | - | 240,740.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 240,740.00 |
| Dec 31, 2025 | 255,776.00 |
| Sep 30, 2025 | 14,271.00 |
| Jun 30, 2025 | 286,499.00 |
| Mar 31, 2025 | 237,647.00 |
| Dec 31, 2024 | 255,177.00 |
| Sep 30, 2024 | 276,839.00 |
| Jun 30, 2024 | 15,317.00 |
| Mar 31, 2024 | 310,929.00 |
| Dec 31, 2023 | 307,655.00 |
| Sep 30, 2023 | 301,423.00 |
| Jun 30, 2023 | 298,047.00 |
| Dec 31, 2022 | 287,384.00 |